These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21813491)

  • 61. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP; Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lamotrigine for agitation in older patients with dementia.
    Ng B; Camacho A; Bardwell W; Sewell DD
    Int Psychogeriatr; 2009 Feb; 21(1):207-8. PubMed ID: 18834559
    [No Abstract]   [Full Text] [Related]  

  • 63. Benzodiazepines and acute psychotic agitation.
    Benazzi F; Mazzoli M; Rossi E
    Can J Psychiatry; 1992 Dec; 37(10):732-3. PubMed ID: 1361879
    [No Abstract]   [Full Text] [Related]  

  • 64. [Withdrawal versus continuation of antipsychotic drugs in people with dementia].
    Lolk A
    Ugeskr Laeger; 2014 Jul; 176(31):. PubMed ID: 25292325
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
    Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
    [No Abstract]   [Full Text] [Related]  

  • 66. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
    Gleason RP; Schneider LS
    J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Risks associated with parenteral treatment of acute agitation].
    Boomsma MM; Mengels O; van Olden RW
    Tijdschr Psychiatr; 2006; 48(2):135-9. PubMed ID: 16958197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Are there any news about the antipsychotic medications in the elderly?
    Cucinotta D; Minardi M; Lanfranchi G; Reggiani A; Savorani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():133-7. PubMed ID: 17317446
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.
    Lawlor B; Bhriain SN
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S2-6. PubMed ID: 11748783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. First generation antipsychotic-induced severe hypothermia: A case report and review of the literature.
    Elbakary NAH; Ouanes S
    Asian J Psychiatr; 2019 Aug; 44():35-37. PubMed ID: 31306860
    [No Abstract]   [Full Text] [Related]  

  • 71. Antipsychotics for agitation in dementia.
    Ton J; Ramji J; Allan GM
    Can Fam Physician; 2018 May; 64(5):369. PubMed ID: 29760258
    [No Abstract]   [Full Text] [Related]  

  • 72. Disappearance of psychosis after buspirone treatment.
    Medrano J; Padierna JA
    Am J Psychiatry; 1996 Feb; 153(2):293. PubMed ID: 8561216
    [No Abstract]   [Full Text] [Related]  

  • 73. Treatment of agitation using Depakote: a patient with dementia.
    Vance H; Kauffman C; Miller B; Mansour T
    Psychiatry; 2003; 66(4):358-9. PubMed ID: 14964697
    [No Abstract]   [Full Text] [Related]  

  • 74. Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.
    Wilkins JM; Forester BP
    Curr Psychiatry Rep; 2016 Feb; 18(2):14. PubMed ID: 26781552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Managing acutely confused elderly patients. Neuroleptics only in the exceptional case!].
    Bischoff A
    MMW Fortschr Med; 2012 Sep; 154(16):18, 20. PubMed ID: 23045928
    [No Abstract]   [Full Text] [Related]  

  • 76. Agitation in the medically ill elderly.
    Alao AO; Soderberg M; Koss M
    West Afr J Med; 2005; 24(2):171-4. PubMed ID: 16092322
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antipsychotic treatment in outpatients with dementia.
    Devanand DP
    Int Psychogeriatr; 1996; 8 Suppl 3():355-61; discussion 381-2. PubMed ID: 9154588
    [No Abstract]   [Full Text] [Related]  

  • 78. Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016.
    Lee EHM; Hui CLM; Law EYL; Chan PY; Chang WC; Chan SKW; Chen EYH
    Schizophr Res; 2018 Jul; 197():618-619. PubMed ID: 29477247
    [No Abstract]   [Full Text] [Related]  

  • 79. A regulatory perspective on psychiatric syndromes in Alzheimer disease.
    Laughren T
    Am J Geriatr Psychiatry; 2001; 9(4):340-5. PubMed ID: 11739061
    [No Abstract]   [Full Text] [Related]  

  • 80. Can decreasing antipsychotic use lead to growth in mental and emotional health?
    Bueckert V
    Alta RN; 2014; 70(2):12-4. PubMed ID: 25137891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.